Phosphorus magnetic resonance spectroscopy in multiple system atrophy and Parkinson's disease

We performed in vivo phosphorus magnetic resonance spectroscopy on the occipital lobes of 15 patients with multiple system atrophy (MSA; eight with olivopontocerebellar atrophy [OPCA] and seven with the striatonigral degeneration variant [SND]), 13 patients with idiopathic Parkinson's disease (PD), and 16 age‐matched healthy subjects. The MSA group showed significantly reduced phosphocreatine (PCr), increased inorganic phosphate (Pi), and unchanged cytosolic free [Mg2+], and pH. We did not find any significant difference between the OPCA and SND variants. However, patients with PD showed significantly increased content of Pi, decreased cytosolic free [Mg2+], and unchanged [PCr] and pH. Comparing the MSA and PD groups, [PCr] was significantly lower in MSA than in PD, whereas cytosolic free [Mg2+] was significantly lower in PD. Despite a certain degree of overlap of [PCr] and [Mg2+] values between the two groups, by considering both variables at the same time it was possible to classify correctly 93% of cases by discriminant analysis. We conclude that phosphorus magnetic resonance spectroscopy discloses abnormal phosphate metabolite and ion contents in both MSA and PD, respectively, and may provide noninvasive diagnostic help to differentiate MSA from PD.

[1]  C. Marsden,et al.  Mitochondrial respiratory chain function in multiple system atrophy , 1997, Movement disorders : official journal of the Movement Disorder Society.

[2]  Peter M. G. Munro,et al.  Inhibition of N-acetylaspartate production: implications for 1H MRS studies in vivo. , 1996, Neuroreport.

[3]  B. Barbiroli,et al.  In Vivo Assessment of Free Magnesium Concentration in Human Brain by 31P MRS. A New Calibration Curve Based on a Mathematical Algorithm , 1996, NMR in biomedicine.

[4]  C. Marsden,et al.  Differentiation of multiple system atrophy from idiopathic Parkinson's disease using proton magnetic resonance spectroscopy , 1995, Annals of neurology.

[5]  N P Quinn,et al.  Clinicopathological study of 35 cases of multiple system atrophy. , 1995, Journal of neurology, neurosurgery, and psychiatry.

[6]  M Konagaya,et al.  Clinical and magnetic resonance imaging study of extrapyramidal symptoms in multiple system atrophy. , 1994, Journal of neurology, neurosurgery, and psychiatry.

[7]  Y. Hashizume,et al.  A study of parkinsonism in multiple system atrophy: clinical and MRI correlation , 1994, Acta neurologica Scandinavica.

[8]  T. Ishikawa,et al.  The Metabolic Topography of Parkinsonism , 1994, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[9]  J. Dichgans,et al.  Multiple system atrophy: natural history, MRI morphology, and dopamine receptor imaging with 123IBZM-SPECT. , 1994, Journal of neurology, neurosurgery, and psychiatry.

[10]  J. Schulz,et al.  Mitochondrial dysfunction in movement disorders , 1994, Current opinion in neurology.

[11]  O. Blin,et al.  Mitochondrial respiratory failure in skeletal muscle from patients with Parkinson's disease and multiple system atrophy , 1994, Journal of the Neurological Sciences.

[12]  S. Gilman,et al.  Patterns of cerebral glucose metabolism detected with positron emission tomography differ in multiple system atrophy and olivopontocerebellar atrophy , 1994, Annals of neurology.

[13]  N P Quinn,et al.  Clinical features and natural history of multiple system atrophy. An analysis of 100 cases. , 1994, Brain : a journal of neurology.

[14]  R. Benecke,et al.  Electron transfer complexes I and IV of platelets are abnormal in Parkinson's disease but normal in Parkinson-plus syndromes. , 1993, Brain : a journal of neurology.

[15]  S. Fahn,et al.  Chronic levodopa administration alters cerebral mitochondrial respiratory chain activity , 1993, Annals of neurology.

[16]  P. Zaniol,et al.  Brain Oxidative Metabolism in Parkinson's Disease Studied by Phosphorus 31 Magnetic Resonance Spectroscopy , 1993 .

[17]  P. Zaniol,et al.  Defective Brain Energy Metabolism Shown by in vivo 31P MR Spectroscopy in 28 Patients with Mitochondrial Cytopathies , 1993, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[18]  P Soliveri,et al.  Response to L-DOPA in multiple system atrophy. , 1993, Clinical neuropharmacology.

[19]  B Kleedorfer,et al.  The dopaminergic response in multiple system atrophy. , 1992, Journal of neurology, neurosurgery, and psychiatry.

[20]  J. Hughes,et al.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. , 1992, Journal of neurology, neurosurgery, and psychiatry.

[21]  C. Marsden,et al.  Anatomic and Disease Specificity of NADH CoQ1 Reductase (Complex I) Deficiency in Parkinson's Disease , 1990, Journal of neurochemistry.

[22]  A. Lees,et al.  Striatonigral degeneration. A clinicopathological study. , 1990, Brain : a journal of neurology.

[23]  G. Dobson,et al.  The Gibbs-Donnan near-equilibrium system of heart. , 1990, The Journal of biological chemistry.

[24]  P. Zaniol,et al.  Complicated Migraine Studied by Phosphorus Magnetic Resonance Spectroscopy , 1990, Cephalalgia : an international journal of headache.

[25]  J A Helpern,et al.  In vivo 31P NMR profiles of Alzheimer's disease and multiple subcortical infarct dementia , 1989, Neurology.

[26]  N. Quinn,et al.  Multiple system atrophy--the nature of the beast. , 1989, Journal of neurology, neurosurgery, and psychiatry.

[27]  C. Hardy,et al.  Rapid, reliable in vivo assays of human phosphate metabolites by nuclear magnetic resonance. , 1989, Clinical chemistry.

[28]  S Nioka,et al.  Multiple controls of oxidative metabolism in living tissues as studied by phosphorus magnetic resonance. , 1986, Proceedings of the National Academy of Sciences of the United States of America.